FGFR inhibition blocks NF-ĸB-dependent glucose metabolism and confers metabolic vulnerabilities in cholangiocarcinoma.
Saved in:
| Title: | FGFR inhibition blocks NF-ĸB-dependent glucose metabolism and confers metabolic vulnerabilities in cholangiocarcinoma. |
|---|---|
| Authors: | Zhen Y; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA, USA.; Dept. of Medicine, Harvard Medical School, Boston, MA, USA.; The Cancer Program, Broad Institute, Cambridge, MA, USA., Liu K; Center for Computational and Integrative Biology, Department of Molecular Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Shi L; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA, USA.; Dept. of Medicine, Harvard Medical School, Boston, MA, USA.; The Cancer Program, Broad Institute, Cambridge, MA, USA., Shah S; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Xu Q; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA, USA.; Dept. of Medicine, Harvard Medical School, Boston, MA, USA.; The Cancer Program, Broad Institute, Cambridge, MA, USA., Ellis H; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA, USA.; Dept. of Medicine, Harvard Medical School, Boston, MA, USA.; The Cancer Program, Broad Institute, Cambridge, MA, USA., Balasooriya ER; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA, USA.; Dept. of Medicine, Harvard Medical School, Boston, MA, USA.; The Cancer Program, Broad Institute, Cambridge, MA, USA., Kreuzer J; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Dept. of Medicine, Harvard Medical School, Boston, MA, USA., Morris R; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Baldwin AS; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, USA., Juric D; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Dept. of Medicine, Harvard Medical School, Boston, MA, USA., Haas W; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Dept. of Medicine, Harvard Medical School, Boston, MA, USA., Bardeesy N; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA. Bardeesy.Nabeel@mgh.harvard.edu.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA, USA. Bardeesy.Nabeel@mgh.harvard.edu.; Dept. of Medicine, Harvard Medical School, Boston, MA, USA. Bardeesy.Nabeel@mgh.harvard.edu.; The Cancer Program, Broad Institute, Cambridge, MA, USA. Bardeesy.Nabeel@mgh.harvard.edu. |
| Source: | Nature communications [Nat Commun] 2024 May 07; Vol. 15 (1), pp. 3805. Date of Electronic Publication: 2024 May 07. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38714664 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: FGFR inhibition blocks NF-ĸB-dependent glucose metabolism and confers metabolic vulnerabilities in cholangiocarcinoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Zhen+Y%22">Zhen Y</searchLink>; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA, USA.; Dept. of Medicine, Harvard Medical School, Boston, MA, USA.; The Cancer Program, Broad Institute, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Liu+K%22">Liu K</searchLink>; Center for Computational and Integrative Biology, Department of Molecular Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Shi+L%22">Shi L</searchLink>; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA, USA.; Dept. of Medicine, Harvard Medical School, Boston, MA, USA.; The Cancer Program, Broad Institute, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Shah+S%22">Shah S</searchLink>; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Xu+Q%22">Xu Q</searchLink>; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA, USA.; Dept. of Medicine, Harvard Medical School, Boston, MA, USA.; The Cancer Program, Broad Institute, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ellis+H%22">Ellis H</searchLink>; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA, USA.; Dept. of Medicine, Harvard Medical School, Boston, MA, USA.; The Cancer Program, Broad Institute, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Balasooriya+ER%22">Balasooriya ER</searchLink>; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA, USA.; Dept. of Medicine, Harvard Medical School, Boston, MA, USA.; The Cancer Program, Broad Institute, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Kreuzer+J%22">Kreuzer J</searchLink>; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Dept. of Medicine, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Morris+R%22">Morris R</searchLink>; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Baldwin+AS%22">Baldwin AS</searchLink>; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, USA.<br /><searchLink fieldCode="AU" term="%22Juric+D%22">Juric D</searchLink>; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Dept. of Medicine, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Haas+W%22">Haas W</searchLink>; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Dept. of Medicine, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Bardeesy+N%22">Bardeesy N</searchLink>; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA. Bardeesy.Nabeel@mgh.harvard.edu.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA, USA. Bardeesy.Nabeel@mgh.harvard.edu.; Dept. of Medicine, Harvard Medical School, Boston, MA, USA. Bardeesy.Nabeel@mgh.harvard.edu.; The Cancer Program, Broad Institute, Cambridge, MA, USA. Bardeesy.Nabeel@mgh.harvard.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2024 May 07; Vol. 15 (1), pp. 3805. <i>Date of Electronic Publication: </i>2024 May 07. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38714664 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-024-47514-y Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3805 Titles: – TitleFull: FGFR inhibition blocks NF-ĸB-dependent glucose metabolism and confers metabolic vulnerabilities in cholangiocarcinoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zhen Y – PersonEntity: Name: NameFull: Liu K – PersonEntity: Name: NameFull: Shi L – PersonEntity: Name: NameFull: Shah S – PersonEntity: Name: NameFull: Xu Q – PersonEntity: Name: NameFull: Ellis H – PersonEntity: Name: NameFull: Balasooriya ER – PersonEntity: Name: NameFull: Kreuzer J – PersonEntity: Name: NameFull: Morris R – PersonEntity: Name: NameFull: Baldwin AS – PersonEntity: Name: NameFull: Juric D – PersonEntity: Name: NameFull: Haas W – PersonEntity: Name: NameFull: Bardeesy N IsPartOfRelationships: – BibEntity: Dates: – D: 07 M: 05 Text: 2024 May 07 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2041-1723 Numbering: – Type: volume Value: 15 – Type: issue Value: 1 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |